

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washingto⦠read more
Healthcare
Biotechnology
5 years
USD
Exclusive to Premium users
$1.94
Price0.00%
$0.00
$245.032m
Small
-
Premium
Premium
-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow Margin$0.00
-
1y CAGR-
3y CAGR-
5y CAGR-$62.814m
+11.3%
1y CAGR-3.3%
3y CAGR-6.2%
5y CAGR-$0.50
+10.7%
1y CAGR-3.3%
3y CAGR+3.3%
5y CAGR$169.139m
$200.915m
Assets$31.776m
Liabilities$27.003m
Debt13.4%
-0.5x
Debt to EBITDA-$53.917m
+12.0%
1y CAGR-4.5%
3y CAGR-7.4%
5y CAGR